Products
SUSTAINABILITY REPORT

Products

Edwards Lifesciences is a leader in patient-focused innovations for structural heart disease and critical care technologies. The Products section of our 2016 Sustainability Report contains our management approach and annual performance for the following material topics:

  • Product Safety & Quality
  • Product Lifecycle, Design & Innovation
  • Supply Chain Management
  • Chemical & Materials Stewardship
HIGHLIGHT STORY
Committed to Environmental Accreditation at our Manufacturing Facilities
VIEW STORY
SUSTAINABILITY TARGETS
Drive continuous improvement efforts to eliminate patient safety-related class 1 product removals.
Excel as a Trusted Partner and Global Leader Through the Quality of Our Work
SUSTAINABILITY TARGETS
Assess lifecycle impacts on packaging designs and product materials for existing products across all business units by 2018.
Strengthen Our Communities
SUSTAINABILITY TARGETS
Obtain reports on product materials from 80% of applicable suppliers by 2018.
Excel as a Trusted Partner and Global Leader Through the Quality of Our Work
SUSTAINABILITY TARGETS
Ensure that 100 percent of our products are conflict mineral free by 2020.
Excel as a Trusted Partner and Global Leader Through the Quality of Our Work
SUSTAINABILITY TARGETS
Connect with top 10 suppliers to provide additional training and patient interactions.
Transform Patient Care Through Innovative Technologies
HIGHLIGHT STORY
Leading Innovation in Heart Valve Therapy: FDA Approves Three New Devices
In 2016, Edwards Lifesciences received approval from The Food and Drug Administration (FDA) for three new devices, including: The advanced EDWARDS INTUITY Elite valve system, a rapid deployment device for surgical aortic valve replacement; CE Mark for our INSPIRIS RESILIA aortic valve, the first in a new class of resilient heart valves; and, CE Mark for our Acumen Hypotension Probability Indicator (HPI), a breakthrough technology that alerts clinicians to potential hypotension, or abnormally low blood pressure, in their surgical and critical care patients before it occurs.

Since 1958, Edwards has led the medical technology industry in patient-focused innovation for therapies that treat structural heart disease. We’ve pioneered developments in surgical, transcatheter and critical care products that enhance and save patient lives. Innovation not only drives our bottom line, but also enables us to continually improve our impacts on society and the environment.

DEFINITION